Evidence map›Paper›PMID 38230400›Full record

ArticleJournal of contemporary brachytherapy2023

Quantifying the effect of eccentric ruthenium plaque placement on tumor volume dose.

Jeremy P M Flanagan, William H F Udovenya, Melvin A Astrahan, Daniel McKay, Claire Phillips, John D McKenzie, Roderick O'Day, Lotte S Fog

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of contemporary brachytherapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jeremy P M FlanaganOphthalmology, Department of Surgery, University of Melbourne, Melbourne (Victoria), Australia.
William H F UdovenyaOphthalmology, Department of Surgery, University of Melbourne, Melbourne (Victoria), Australia.
Melvin A AstrahanDepartment of Radiation Oncology, Keck School of Medicine, University of Southern California, Los Angeles (California), USA.
Daniel McKayOcular Oncology Research Unit, Centre for Eye Research Australia, Melbourne (Victoria), Australia.
Claire PhillipsDepartment of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne (Victoria), Australia.
John D McKenzieDepartment of Ocular Oncology, Royal Victorian Eye and Ear Hospital, Melbourne (Victoria), Australia.
Roderick O'DayOcular Oncology Research Unit, Centre for Eye Research Australia, Melbourne (Victoria), Australia.
Lotte S FogDepartment of Ocular Oncology, Royal Victorian Eye and Ear Hospital, Melbourne (Victoria), Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Ruthenium-106 brachytherapy is a common treatment for small to medium-sized uveal melanomas. In certain clinical contexts, plaques may be placed eccentrically to tumor center. The effect of plaque decentration, a common radiation dose measurement in radiotherapy: D Material and methods: Using a Plaque Simulator™ (Eye Physics) plaque modelling software, treatment time required to deliver 100 Gy D Results: D Conclusions: Eccentric plaque placement reduces the radiation dose delivered to choroidal tumors. Both tumor (thickness, diameter) and plaque (size, location) characteristics are important D

Indexed as

brachytherapyeccentricmelanomaruthenium

Identifiers

PMID38230400
PMCPMC10789163

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.